Takeda Pharmaceutical Company will transfer its Japan consumer healthcare business unit to Takeda Consumer Healthcare Company Limited (TCHC), its wholly owned subsidiary.
Takeda announced its intention to spin-off its Japan Consumer Healthcare Business Unit in February 2016, in order to realize a more agile business model to promptly meet environmental changes and customers’ needs in the consumer healthcare market.
The Japan consumer healthcare business unit has been focusing on over-the counter medicines including Alinamin and Benza, and a health food named Midori-no-Shukan.
Read the Takeda press release